Serum neurofilament light levels are correlated to long-term neurocognitive outcome measures after cardiac arrest

Brain Inj. 2022 May 12;36(6):800-809. doi: 10.1080/02699052.2022.2048693. Epub 2022 Mar 5.

Abstract

Objective: To explore associations between four methods assessing long-term neurocognitive outcome after out-of-hospital cardiac arrest and early hypoxic-ischemic neuronal brain injury assessed by the biomarker serum neurofilament light (NFL), and to compare the agreement for the outcome methods.

Methods: An explorative post-hoc study was conducted on survivor data from the international Target Temperature Management after Out-of-hospital Cardiac Arrest trial, investigating serum NFL sampled 48/72-hours post-arrest and neurocognitive outcome 6 months post-arrest.

Results: Among the long-term surviving participants (N = 457), serum NFL (n = 384) was associated to all outcome instruments, also when controlling for demographic and cardiovascular risk factors. Associations between NFL and the patient-reported Two Simple Questions (TSQ) were however attenuated when adjusting for vitality and mental health. NFL predicted results on the outcome instruments to varying degrees, with an excellent area under the curve for the clinician-report Cerebral Performance Category (CPC 1-2: 0.90). Most participants were classified as CPC 1 (79%). Outcome instrument correlations ranged from small (Mini-Mental State Examination [MMSE]-TSQ) to strong (CPC-MMSE).

Conclusions: The clinician-reported CPC was mostly related to hypoxic-ischemic brain injury, but with a ceiling effect. These results may be useful when selecting methods and instruments for clinical follow-up models.

Keywords: Hypoxic-ischemic encephalopathy; biomarker; cardiovascular disease; cognitive impairment; heart arrest.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biomarkers
  • Brain Injuries*
  • Humans
  • Intermediate Filaments
  • Neurofilament Proteins
  • Out-of-Hospital Cardiac Arrest*
  • Outcome Assessment, Health Care

Substances

  • Biomarkers
  • Neurofilament Proteins